Department of Internal Medicine and Medical Therapeutics, University of Pavia, Italy; Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Italy.
Federico Biagi studies various gastrointestinal conditions and how certain procedures, particularly colonoscopies, can be optimized for better patient outcomes. His research includes examination of bowel preparation methods for patients with ulcerative colitis, showing which methods yield the best results for effective screenings. He also looks into long-term health impacts for patients with nonceliac enteropathies and the prevalence of infections like Helicobacter pylori in diseases like Whipple's disease. Biagi’s work provides insights that help doctors make informed decisions regarding necessary procedures and treatment strategies for their patients suffering from these conditions.
Key findings
Terminal ileal intubation during asymptomatic colonoscopy detected significant health issues in only 0.28% of cases, indicating it may be unnecessary.
In a study of ulcerative colitis patients, 90.5% achieved adequate bowel preparation before colonoscopy, with the 1L-PEG-ASC method being significantly more effective.
In a cohort of nonceliac enteropathy patients, mortality rates were three times higher than the general population, with a model created to identify those at higher risk.
38% of patients with Whipple's disease also had Helicobacter pylori infections, compared to just 12% in controls, highlighting the need for targeted management in these patients.
Of patients with autoimmune gastritis, only 0.9% developed gastric cancer, but 9.6% developed gastric neuroendocrine neoplasms, indicating the importance of monitoring patients with vitamin B12 deficiencies.
Frequently asked questions
Does Dr. Biagi study celiac disease?
Yes, he studies the effects of celiac disease on work impairment and factors that contribute to ongoing symptoms in patients.
What treatments has Dr. Biagi researched?
He investigates the effectiveness of different bowel preparation methods for colonoscopies and various treatment implications related to infections like Helicobacter pylori.
Is Dr. Biagi's work relevant to ulcerative colitis patients?
Absolutely; his research focuses on bowel preparation techniques that are crucial for patients with ulcerative colitis during colonoscopy.
How does Dr. Biagi's research affect diagnostic procedures?
His findings help determine which procedures are necessary during colonoscopies, potentially avoiding unnecessary ones that add time but offer little benefit.
What can I learn from Dr. Biagi's studies about Whipple's disease?
His research highlights the high prevalence of Helicobacter pylori infection in patients with Whipple's disease, which can influence treatment strategies.
Publications in plain English
Use of a humanoid robot to reduce distress in autistic children undergoing paediatric cardiology visits: a pilot study.
2026
BMJ paediatrics open
Lodi E, Tampieri F, Poli ML, Rodighiero E, Gasparini PA +2 more
Plain English This study looked at how a humanoid robot named NAO could help reduce anxiety in children with autism during heart check-ups. In the study, 24 children showed less distress when the robot was present compared to their visits without the robot, and the check-up procedures were completed more smoothly and quickly. This is important because it shows that using robots in medical settings can make visits easier and more comfortable for children with autism.
Who this helps: Patients with autism and their families.
Work Impairment in Patients with Celiac Disease and Its Relationship with Persistence of Symptoms, Dietary Adherence, Quality of Life, and Psychological Morbidity.
2026
Digestive diseases and sciences
Dota M, Rubbini L, Massetti G, Scarcella C, Maimaris S +6 more
Plain English This study looked at how celiac disease affects people’s ability to work and the reasons they miss work. Out of 167 patients, 14% missed work in the past month, averaging about 6.6 hours lost. Those who missed work experienced more ongoing symptoms, higher depression levels, and a lower quality of life compared to those who did not miss work, showing that persistent symptoms and being on a gluten-free diet for less than a year are key factors.
Who this helps: This information benefits patients with celiac disease and their doctors.
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseases.
2026
Clinical and experimental rheumatology
Maimaris S, Germanò G, Torre A, Bianco C, Bianchi PI +13 more
Plain English This study looked at how common Whipple's disease (WD) is among patients with inflammatory rheumatic diseases. Out of over 23,000 patients, only 0.03% were diagnosed with WD, but among those suspected of having it, the prevalence jumped to nearly 16%, especially higher in males at around 24%. These findings highlight the need for doctors to be more aware of WD in rheumatology settings, which could help reduce delays in diagnosis and prevent the unnecessary use of treatments.
Who this helps: This helps doctors and patients who may experience unexplained symptoms.
DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
2026
Gastrointestinal endoscopy
Scalvini D, Maimaris S, Cappellini A, Lusetti F, Delogu C +12 more
Plain English The study looked at whether an additional procedure called terminal ileal intubation (TII) is useful during colonoscopies for people who don’t have any symptoms, specifically for colorectal cancer screening or after polyp removal. Researchers reviewed data from 11 studies involving over 25,000 patients and found that TII only detected important issues in 0.28% of cases and Crohn's disease in just 0.1% of cases, meaning it doesn’t significantly improve the chances of finding serious health problems. This matters because it suggests that doing TII for these patients is unnecessary and may just add time to the procedure without providing real benefits.
Who this helps: This helps doctors and patients by clarifying which procedures are necessary during colonoscopy.
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.
2026
Diagnostics (Basel, Switzerland)
Scalvini D, Maimaris S, Stasi E, Valvano M, Brinch D +21 more
Plain English This study looked at how well patients with ulcerative colitis (UC) prepare their bowels for colonoscopies when their disease is under control, and compared two different bowel prep methods. Among 379 patients, 90.5% had adequate bowel preparation, but those using the 1L-PEG-ASC method scored better on cleanliness (8 out of 9) compared to those using 2L-PEG (6 out of 9) and had a higher exam completion rate (99.5% vs. 95.7%). This is important because it shows that even without active disease, good bowel prep is essential for effective cancer screenings, highlighting the benefits of using the 1L-PEG-ASC method for better results.
Who this helps: Patients with ulcerative colitis needing colonoscopies.
The use of the social robot NAO in medical settings: how to facilitate interactions between healthcare professionals and patients with autism spectrum disorder.
2025
Frontiers in psychiatry
Biagi F, Iani C, Biagiotti L
Plain English This study looked at how a social robot named NAO can help healthcare professionals interact with children who have Autism Spectrum Disorder (ASD). Researchers developed two ways to control the robot: one where doctors manually operate it and another that uses voice commands. Twenty-three doctors tested both methods and found that while both were user-friendly, the voice-command method was preferred for its ease of use, indicating that the robot could make medical visits less stressful for children with ASD.
Who this helps: This benefits children with Autism Spectrum Disorder and their healthcare providers.
Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies.
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Schiepatti A, Cappellini A, Maimaris S, Minerba P, Retrosi M +7 more
Plain English This study looked at a marker called fecal calprotectin (FC) to understand its role in measuring gut inflammation in patients with celiac disease (CD) and non-celiac enteropathies (NCEs). The researchers found that 55 out of 177 patients had high levels of FC, which made it likely they would have more complications or die earlier; specifically, those with high FC levels were four times more likely to face these outcomes. This matters because it indicates that measuring FC can help doctors identify patients at greater risk for severe disease and complications.
Who this helps: This helps patients with celiac disease and non-celiac enteropathies, as well as their doctors, by providing a simple way to assess disease risk.
Diagnostic outcomes after gluten challenge in adult patients with unconfirmed coeliac disease already on a gluten-free diet: A 20-year retrospective cohort study.
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Maimaris S, Schiepatti A, Saracino M, Ongarelli L, Torres DIC +3 more
Plain English This study looked at adults who were on a gluten-free diet but had not yet been confirmed to have coeliac disease. Out of 158 patients tested after eating gluten for about 3 months, only 47 (about 30%) were confirmed to have coeliac disease, while most (108) did not have the disease. The findings highlight that a previous positive blood test for gluten sensitivity greatly increases the chances of actually having the disease, but doctors should be careful about interpreting other test results, especially in older patients with severe symptoms.
Who this helps: This helps patients with suspected coeliac disease and their doctors in making more accurate diagnoses.
Prevalence of gastroesophageal reflux disease in adult coeliac disease at diagnosis and during follow-up: a 20-year retrospective study.
2025
European journal of gastroenterology & hepatology
Maimaris S, Mangili L, Minerba P, Massetti G, Scarcella C +2 more
Plain English This study looked at the occurrence of gastroesophageal reflux disease (GORD) in adults diagnosed with coeliac disease over a 20-year period. Initially, 16.8% of participants reported reflux symptoms at the time of their coeliac diagnosis, but only 21.9% of those continued to have these symptoms after following a gluten-free diet for about 16 months. Overall, during long-term follow-up, 20.8% of patients experienced ongoing reflux symptoms, showing that while many improve with dietary changes, some develop reflux after starting the diet, highlighting ongoing monitoring is important.
Who this helps: This helps patients with coeliac disease and their doctors by providing insights into managing reflux symptoms associated with the condition.
Biopsy-Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment.
2025
Alimentary pharmacology & therapeutics
Maimaris S, Schiepatti A, Conforme Torres DI, Muscia R, Gregorio V +9 more
Plain English This study evaluated a new way to diagnose coeliac disease in adults without the need for invasive biopsies. Researchers looked at nearly 1,200 patients and found that 35.4% had coeliac disease, with an impressive accuracy of 99.1% using a blood test for antibodies. This matters because it suggests that many younger patients with mild symptoms might be diagnosed safely without needing uncomfortable procedures, while older patients with severe symptoms still require further testing to rule out other conditions.
Who this helps: This helps patients suspected of having coeliac disease, especially younger ones.
Remineralizing Treatments for Dental Erosion and Sensitivity in Patients Suffering from Gastroesophageal Reflux Disease (GERD): Randomized Clinical Trial.
2025
Journal of clinical medicine
Scribante A, Pardo A, Pascadopoli M, Biagi F, Schiepatti A +6 more
Plain English This study looked at how effective two different dental treatments were for people with tooth erosion caused by gastroesophageal reflux disease (GERD). Thirty patients participated, with one group using a special toothpaste and an additional paste, and the other group using just the toothpaste. While the extra paste didn’t make a significant difference in overall tooth erosion and sensitivity scores, patients using the treatments saw improvements in sensitivity and plaque control.
Who this helps: Patients with GERD who experience dental erosion and sensitivity.
Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review.
2025
International journal of molecular sciences
Maimaris S, Scarcella C, Memoli GA, Crisciotti C, Schiepatti A +1 more
Plain English This paper looked at non-coeliac wheat sensitivity (NCWS), a condition where people experience symptoms like stomach issues and fatigue after eating wheat, even though they don't have coeliac disease or a wheat allergy. The study found that while more than 10% of people report having this condition, only about 30% can be confirmed with careful testing. Understanding NCWS is important because it can impact how people manage their diet, and clearer diagnostic tools are needed to help both patients and healthcare providers.
Who this helps: This helps patients who suspect they have non-coeliac wheat sensitivity and may benefit from better diagnosis and management options.
Endoscopic techniques for the identification of duodenal villous atrophy in celiac disease: a systematic review and meta-analysis of diagnostic accuracy.
2025
Gastrointestinal endoscopy
Maimaris S, Baschiera G, Sammartino C, Memoli GA, Crisciotti C +4 more
Plain English This research paper looked at different endoscopic techniques, which are procedures using a camera, to diagnose villous atrophy in patients with celiac disease. The study found that standard white-light endoscopy is good but has lower accuracy, with a sensitivity of 81.4% and specificity of 95.3%. In contrast, advanced techniques like water-immersion, narrow-band imaging, and dye-based chromoendoscopy performed much better, with sensitivities above 92% and specificities above 93%. This matters because accurate diagnosis can lead to better treatment for patients suffering from celiac disease.
Who this helps: Patients with celiac disease seeking accurate diagnosis.
An Unusual Presentation of Cronkhite-Canada Syndrome With Hypothyroidism.
2025
Case reports in medicine
Crisciotti C, Marchese A, De Cata P, Vjero K, Vattiato C +3 more
Plain English This study examined a rare condition known as Cronkhite-Canada syndrome (CCS) in an elderly man who was initially diagnosed with Crohn's disease. He experienced severe weight loss and symptoms like taste changes, and tests revealed he had low thyroid hormone levels and gastrointestinal polyps. The case underscores the difficulties in diagnosing CCS and emphasizes the importance of recognizing it early for effective treatment, particularly since it may be linked to autoimmune problems.
Who this helps: This benefits doctors and patients who may encounter diagnostic challenges with gastrointestinal symptoms.
Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy.
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Zingone F, Norman GL, Smecuol E, Maniero D, Carroccio A +8 more
Plain English This study examined whether testing for two specific antibodies, tTG IgA and DGP IgG, can accurately diagnose celiac disease without needing a biopsy. Researchers found that if patients tested positive for both antibodies at high levels, the likelihood of actually having celiac disease was very high—92.5% for any positive and 100% for those with extremely high levels. This is important because it offers a less invasive and simpler way to diagnose celiac disease, potentially improving patient care.
Who this helps: This benefits patients suspected of having celiac disease, making diagnosis easier and less intrusive.
Long-term Prognosis of Nonceliac Enteropathies and a Score to Identify Patients With Poor Outcomes: A 30-year Multicenter Longitudinal Study.
2025
The American journal of gastroenterology
Schiepatti A, Maimaris S, Scalvini D, Raju SA, Ingham KE +18 more
Plain English This study looked at the long-term health outcomes of patients with nonceliac enteropathies (NCEs), which are digestive disorders not related to celiac disease, over a period of 30 years. Researchers found that 10 years after diagnosis, about 74% of patients were still alive, but mortality rates were significantly higher for these patients compared to the general population, with a mortality rate about three times higher. They created a scoring system to identify patients at higher risk of serious health issues, allowing for better monitoring and personalized treatment plans.
Who this helps: This research benefits patients with nonceliac enteropathies and their doctors by providing insights for better management and care.
Citone M, Annese A, Gabbani G, Pindozzi F, Falcone G +17 more
Plain English This study examined a patient with severe bleeding due to complications from high blood pressure in the portal vein, caused by abnormal blood vessels in the liver. The researchers found that while blocking these abnormal vessels helped with some issues, it did not stop the bleeding, so they used a procedure called TIPS to manage the situation. This approach successfully resolved the bleeding and prevented life-threatening complications.
Who this helps: This helps patients with severe liver-related complications and their doctors in managing difficult cases.
Applications of generative artificial intelligence in inflammatory bowel disease: A systematic review.
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Lusetti F, Maimaris S, La Rosa GP, Scalvini D, Schiepatti A +4 more
Plain English This study looked at how generative artificial intelligence, like ChatGPT, can help with managing inflammatory bowel diseases (IBD), which are chronic conditions that can significantly affect patients' lives. Researchers reviewed 8 studies and found that ChatGPT gave accurate information for patient education 84.2% of the time, and effectively assisted doctors in classifying illness severity 80% of the time. However, there were still concerns about accuracy and consistency, so expert supervision is necessary before it can be widely used in medical practice.
Who this helps: This benefits patients with inflammatory bowel disease and their doctors.
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting.
2025
European journal of gastroenterology & hepatology
Scalvini D, Bezzio C, Maimaris S, Lenti MV, Francesca L +18 more
Plain English In this study, researchers compared two types of bowel preparation methods, 1L-PEG-ASC and 2L-PEG, for patients with inflammatory bowel disease (IBD) undergoing outpatient colonoscopy. They found that 1L-PEG-ASC was more effective, with 89.8% of patients achieving adequate preparation compared to 83.8% with 2L-PEG. Additionally, factors like being male, having a history of specific surgeries, and having stricturing Crohn’s disease were linked to poorer preparation results.
Who this helps: This benefits patients with IBD who need effective bowel preparation before a colonoscopy.
Whipple's disease: A rare disease that can be spotted by many doctors.
2024
European journal of internal medicine
Cappellini A, Minerba P, Maimaris S, Biagi F
Plain English The study looks at Whipple's disease, a rare infection that affects multiple organs and is often hard to diagnose because its early symptoms are similar to other conditions. The research highlights that doctors from various specialties need to be aware of this disease to make accurate diagnoses, especially once gastrointestinal symptoms appear. Early detection is crucial since untreated cases can lead to serious complications, including severe brain issues.
Who this helps: This helps patients who may have Whipple's disease and their doctors, by improving awareness and diagnosis of the condition.
Valorization of Winery By-Products as Bio-Fillers for Biopolymer-Based Composites.
2024
Polymers
Biagi F, Giubilini A, Veronesi P, Nigro G, Messori M
Plain English This study looked at using waste materials from wineries—grape seeds, wine lees, and grape pomace—as fillers in eco-friendly plastics made from biopolymers. The researchers found that adding these by-products not only preserved but significantly increased the stiffness of the plastics, with some samples showing a 162% increase in stiffness. This approach not only helps make more sustainable materials but also reduces waste and costs in production.
Who this helps: This benefits manufacturers looking for sustainable materials and the environment by reducing waste.
Frailty after Liver Transplantation: A Complex Unexplored Issue.
2024
Journal of clinical medicine
Gabrielli F, Biagi F, Avossa A, Falcini M, Nascimbeni F +2 more
Plain English This paper studied frailty in patients who have received liver transplants, highlighting that these individuals often experience increased health risks and lower quality of life. The authors found that factors like income, culture, and overall health can make frailty more likely, and patients with frailty face higher chances of being hospitalized and even dying. Notably, effective assessment tools for frailty specific to liver transplant patients are lacking, but incorporating social and psychological factors could improve their care and outcomes.
Who this helps: This helps liver transplant patients and their healthcare providers.
Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies.
2024
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Schiepatti A, Maimaris S, Scarcella C, Pignatti P, Betti E +4 more
Plain English This study looked at how flow cytometry (a lab technique) can help monitor a type of immune cell called intraepithelial lymphocytes (IELs) in patients with difficult-to-treat celiac disease and other related conditions. Researchers found that 22 of the 52 patients had consistent IEL characteristics over time, and having an abnormal IEL profile was linked to a higher risk of death (over four times more likely). This is important because it shows that flow cytometry can provide valuable insights into the health of these patients and help inform their treatment.
Who this helps: This research benefits patients with celiac disease and their doctors by improving monitoring and treatment strategies.
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers.
2024
Alimentary pharmacology & therapeutics
Schiepatti A, Minerba P, Puricelli M, Maimaris S, Arpa G +2 more
Plain English This study examined the problems caused by a type of medication called angiotensin II receptor blockers (ARBs) that can lead to a serious intestinal condition. Researchers analyzed 94 articles, finding that 183 patients, mostly older adults, experienced severe diarrhea (97%) and significant weight loss (84%), which often required hospital stays. Importantly, stopping the medication led to recovery in all patients who needed it, highlighting the importance of recognizing this issue so patients can be treated effectively.
Who this helps: This helps patients taking ARBs, especially those experiencing gastrointestinal issues, as well as their doctors in diagnosing and managing the condition.
Systematic review with meta-analysis: Cause-specific and all-cause mortality trends across different coeliac disease phenotypes.
2024
Alimentary pharmacology & therapeutics
Maimaris S, Schiepatti A, Biagi F
Plain English This study looked at death rates in people with coeliac disease and compared them to the general population to see how different types of coeliac disease and other factors affect mortality. The researchers found that people with coeliac disease have a 16% higher risk of dying from all causes, a 21% higher risk from cancers, and a notably higher 10 times the risk from non-Hodgkin lymphoma. However, death rates have decreased over the last few decades, especially since 2015.
Who this helps: This information benefits doctors and patients with coeliac disease by providing clearer insights into risks and improving treatment approaches.
New entity of adult ultra-short coeliac disease: the first international cohort and case-control study.
2024
Gut
Raju SA, Greenaway EA, Schiepatti A, Arpa G, Vecchione N +26 more
Plain English This study focused on a newly identified form of coeliac disease called ultra-short coeliac disease (USCD), which affects the duodenal bulb only. Researchers compared 137 patients with USCD to those with conventional coeliac disease, finding that USCD patients were younger (27 vs. 38 years) and had lower levels of specific antibodies (IgA-tTG) but experienced similar symptoms. Notably, almost all (95.7%) USCD patients saw their symptoms improve after starting a gluten-free diet, highlighting the importance of targeted testing during diagnosis.
Who this helps: This research benefits patients with ultra-short coeliac disease and their doctors by improving diagnosis and treatment options.
Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.
2024
Nutrients
Lusetti F, Schiepatti A, Scalvini D, Maimaris S, Biagi F
Plain English This study looked at whether a low-FODMAP diet could help people with celiac disease who still had IBS-like symptoms even after following a gluten-free diet. Researchers reviewed six studies involving 115 celiac patients and found that those on a low-FODMAP gluten-free diet experienced a significant reduction in symptoms compared to those on a regular gluten-free diet. This matters because it offers a possible solution for patients with lingering digestive issues despite strict adherence to their current diet.
Who this helps: This helps celiac patients who continue to experience uncomfortable gut symptoms.
Superior bowel preparation quality for colonoscopy with 1L-PEG compared to 2L-PEG and picosulphate: Data from a large real-world retrospective outpatient cohort.
2024
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Scalvini D, Lenti MV, Maimaris S, Lusetti F, Alimenti E +12 more
Plain English This study looked at different bowel preparation methods for colonoscopies to see which one worked best in real-life settings. Researchers found that using a 1-liter PEG solution led to better bowel cleanliness compared to 2-liter PEG and picosulphate, with a 2.3 times higher chance of having an adequate preparation. This matters because it can make colonoscopies more effective, reduce the need for follow-up procedures, and save healthcare costs.
Who this helps: This benefits patients undergoing colonoscopies and healthcare providers aiming for better outcomes.
Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single-center prospective study.
2024
Journal of digestive diseases
Schiepatti A, Bossert I, Cincotta M, Zanini CA, Maimaris S +3 more
Plain English This study examined how well the SeHCAT test predicts the effectiveness of cholestyramine treatment in patients with chronic diarrhea suspected to be caused by bile acid malabsorption. Among 50 patients, 37 participated, and those with a positive SeHCAT test showed a long-term response to cholestyramine at a rate of 100%, compared to 65.2% for those with a negative test. This matters because it shows that the SeHCAT test helps identify patients who are more likely to need ongoing treatment for their symptoms, although cholestyramine can still help others who test negative.
Who this helps: Patients with chronic diarrhea and their doctors.
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient.
2024
Clinical journal of gastroenterology
Mollica L, Quaquarini E, Schiepatti A, Travaglino E, Antoci F +4 more
Plain English This study reported on a 62-year-old man with celiac disease who was diagnosed with a rare type of small bowel cancer called adenocarcinoma after experiencing abdominal pain and bleeding. He underwent surgery to remove the cancer, which was at an advanced stage, and genetic testing revealed a specific mutation in the DDR2 gene. After surgery, he received six months of chemotherapy and remains cancer-free nearly three years later, demonstrating that genetic changes in tumors might help in finding targeted treatments for similar patients.
Who this helps: Patients with rare small bowel cancers and their doctors.
Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease.
2024
Frontiers in nutrition
Scalvini D, Scarcella C, Mantica G, Bartolotta E, Maimaris S +3 more
Plain English This study looks at treatments for coeliac disease, a condition affecting about 1% of people, where eating gluten from foods like wheat can damage the intestines. While a strict gluten-free diet is the main treatment, many patients struggle to follow it due to its high cost and difficulty, and some even face serious health issues as a result. The research reviews new drug treatments that are being tested in clinical trials to help patients who can't adhere to the diet or need additional support.
Who this helps: This helps coeliac disease patients seeking alternatives to a gluten-free diet.
Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort.
2024
Frontiers in medicine
Sakellariou G, Schiepatti A, Zanetti A, Montecucco C, Biagi F +1 more
Plain English This study looked at how common celiac disease (CD) is among people with rheumatoid arthritis (RA) compared to those without it. Researchers found that 0.24% of people with RA had CD, compared to 0.14% of those without RA. The increase was particularly notable in women with RA, with a prevalence of 0.3% versus 0.08% in female controls. This is important because it shows that women with RA are more likely to have celiac disease, highlighting a need for more awareness and testing in this group.
Who this helps: This helps patients with rheumatoid arthritis, especially women, by encouraging better screening for celiac disease.
Resilience in Adult Coeliac Patients on a Gluten-Free Diet: A Cross-Sectional Multicentre Italian Study.
2024
Nutrients
Schiepatti A, Maimaris S, Randazzo S, Maniero D, Biti R +8 more
Plain English In this study, researchers looked at how well adults with coeliac disease (a condition that requires a strict gluten-free diet) can bounce back from challenges in life. They found that 98% of the 305 patients had a high level of resilience. However, those with higher anxiety and depression tended to have lower resilience, indicating that addressing these mental health issues could help improve their overall well-being.
Who this helps: This research benefits patients with coeliac disease and healthcare providers managing their care.
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO).
2024
The American journal of gastroenterology
Lenti MV, Miceli E, Lahner E, Natalello G, Massironi S +31 more
Plain English Researchers studied patients with autoimmune gastritis (AIG) to understand how previous infections with Helicobacter pylori (a type of bacteria) or specific antibodies affect their health. They found that only 0.9% of patients developed gastric cancer, while 9.6% developed a type of tumor called gastric neuroendocrine neoplasm (gNEN), with a higher risk for those showing vitamin B12 deficiency at the time of diagnosis. This information is important because it helps identify which patients might need closer monitoring, particularly those with vitamin B12 issues.
Who this helps: Patients with autoimmune gastritis and their doctors.
The effect of the COVID-19 disruption on the gender gap in students' performance: a cross-country analysis.
2023
Large-scale assessments in education
Bertoletti A, Biagi F, Di Pietro G, Karpiński Z
Plain English This study looked at how school closures during COVID-19 affected the performance of eighth-grade boys and girls in four countries: Russia, Slovenia, Uzbekistan, and the United Arab Emirates. It found that girls reported feeling less positive about their learning changes than boys did, with their chances of having a favorable view about their progress being 20-25% lower than boys. The main reasons for this gap included differences in physical activity, psychological distress, and family environment during the disruption. Addressing these issues could help improve educational outcomes for girls.
Who this helps: This helps educators and policymakers aiming to promote gender equality in education.
Non-cognitive skills and social gaps in digital skills: Evidence from ICILS 2018.
2023
Learning and individual differences
Karpiński Z, Di Pietro G, Biagi F
Plain English This study examined how personal qualities like motivation and ambition (known as non-cognitive skills) affect students' digital skills, using data from a 2018 international survey. The results showed that these non-cognitive skills significantly influence students' scores on digital literacy tests, and that there are notable differences in these skills based on gender, immigrant background, and income levels. Understanding these factors is crucial because it highlights the complexity of assessing digital skills and the inequalities that may exist.
Who this helps: This helps educators and policymakers address inequalities in digital education.
Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication.
2023
Metabolites
Biagi F, Carlomagno F, Carbone M, Veralli R, Vespasiani-Gentilucci U +6 more
Plain English This study looked at the levels of a protein called FGF-21 in patients with chronic hepatitis C who were receiving treatment to eliminate the virus. It found that after treatment, FGF-21 levels increased in all 45 patients, while measures of liver stiffness decreased, indicating improved liver health. This is important because it suggests FGF-21 could be a useful indicator of liver damage and recovery after hepatitis C treatment.
Who this helps: This helps patients with chronic hepatitis C and their doctors.
DQA1*0102 DQB1*0602 haplotype distinguishes coeliac disease and its complications from gluten unrelated enteropathies.
2023
European journal of gastroenterology & hepatology
De Silvestri A, Schiepatti A, Fowler BD, Badulli C, Belvisi F +8 more
Plain English This study looked at the genetic markers of patients with noncoeliac enteropathies, which are conditions that cause gut damage but aren't related to gluten, in comparison to patients with coeliac disease. Researchers found that a specific genetic marker, DQA1*0102 DQB1*0602, was much more common in those with noncoeliac enteropathies than in those with coeliac disease—signifying that this marker can help distinguish between these conditions. This matters because better identification of the type of gut disorder can lead to more accurate treatment and management for patients.
Who this helps: Patients with gut disorders, including those affected by noncoeliac enteropathies.
Humoral immunogenicity of COVID-19 vaccines in patients with coeliac disease and other noncoeliac enteropathies compared to healthy controls.
2023
European journal of gastroenterology & hepatology
Scalvini D, Schiepatti A, Maimaris S, Cosentini E, Muscia R +6 more
Plain English This research studied how well COVID-19 vaccines work in patients with celiac disease, Whipple's disease, and other digestive disorders compared to healthy individuals. The findings showed that people with celiac disease had similar antibody levels after vaccination as healthy controls, while those with Whipple's disease had a significantly lower response, with those on immunosuppressive treatments showing very low antibody levels (14 compared to 520 BAU/mL). This is important because it highlights that celiac disease patients are adequately protected by the vaccines, but others, particularly those with Whipple's disease and on immunosuppressants, may need extra attention and booster shots.
Who this helps: This helps patients with celiac disease, doctors managing their care, and those with Whipple's disease.
Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients.
2023
Gut
Schiepatti A, Maimaris S, Raju SA, Green OL, Mantica G +8 more
Plain English This study examined the long-term effects of persistent villous atrophy (pVA) in adults with coeliac disease who are supposed to be on a gluten-free diet. Among 694 patients, 23% had pVA, and these patients faced a significantly higher risk of complications (nearly 10 times more likely) and a 3 times higher chance of dying compared to those without pVA. Researchers created a 5-point risk score to help identify patients at higher risk of pVA, with those scoring high having a 73% chance of having pVA.
Who this helps: This helps doctors identify high-risk patients with coeliac disease who may need closer monitoring.
Clinical and laboratory predictors and prevalence of immune reconstitution inflammatory syndrome in patients with Whipple's disease.
2023
Journal of digestive diseases
Gregorio V, Albrizio A, Maimaris S, Scalvini D, Scarcella C +3 more
Plain English This study examined patients with Whipple's disease (WD) to understand who is at higher risk of developing a serious complication called immune reconstitution inflammatory syndrome (IRIS). Among 45 patients, those who later developed IRIS had significantly lower rates of inflammation and platelet counts, with values like an average erythrocyte sedimentation rate of 33.4 mm/h compared to 67.1 mm/h for those who didn't develop IRIS. The study also found that the rate of IRIS in these patients has remained constant over the past 20 years at 22.2%.
Who this helps: This information helps doctors identify and manage patients with Whipple's disease who are at greater risk for developing IRIS.
Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
2023
The lancet. Gastroenterology & hepatology
Ciacci C, Bai JC, Holmes G, Al-Toma A, Biagi F +15 more
Plain English This study looked at how effective a blood test measuring anti-tissue transglutaminase IgA (tTG-IgA) is for diagnosing coeliac disease in adults who are suspected to have the condition. The research included 436 people, finding that 83% had positive tTG-IgA results, with 95.9% of those confirmed to have coeliac disease through later biopsy evaluation. This matters because it shows that in adults with a strong suspicion of coeliac disease, a blood test might be enough to confirm the diagnosis, potentially avoiding unnecessary biopsies.
Who this helps: This helps patients suspected of having coeliac disease.
Patients with Whipple's disease have a high prevalence of Helicobacter pylori infection.
2023
European journal of internal medicine
Scalvini D, Cambieri P, Schiepatti A, Maimaris S, Lusetti F +4 more
Plain English This study looked at patients with Whipple's disease, a rare infection, to see how often they also had Helicobacter pylori (H. pylori) infections. The researchers found that 38% of Whipple’s disease patients had H. pylori infections compared to only 12% of people without the disease, which is a significant difference. This matters because H. pylori can cause serious stomach problems, including cancer, and knowing this can help doctors better manage treatment for their patients with Whipple's disease.
Who this helps: Patients with Whipple's disease and their doctors.